Skip to content

To observe how KARAVIRADYA TAILA work in PAMA skin disease in children

A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF KARAVIRADYA TAILA IN MANAGEMENT OF PAMA KUSHTA IN CHILDREN - To check the efficacy of drug so patients are selected randomly

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077799
Enrollment
40
Registered
2024-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B86- Scabies

Interventions

None listed

Sponsors

DR ASHWITH A
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subject to fulfil the diagnostic criteria. 2. irrespective of gender, religion and socioeconomic status. 3. Age between the age group 6-16 years.

Exclusion criteria

Exclusion criteria: 1. Kustha other than Pama. 2. Subjects with any other systemic disorder.

Design outcomes

Primary

MeasureTime frame
40 sample size divided into 2 groups of 20 each group A and group BTimepoint: 2weeks(15 days)

Secondary

MeasureTime frame
to reduce the outcome of Shyava Aruna Varna pidika( black head papules , vesicles), Srava ( discharge), Kandu paridaha (pruritis), Toda( pain)Timepoint: 15days

Countries

India

Contacts

Public ContactDr Narayan Pai B

Alvas Ayurveda Medical College and Hospital,Vidyagiri, Moodubidre ,Dakshina Kannada

drnarayanpai@gmail.com9902329719

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026